Zacks Investment Research Downgrades Vitamin Shoppe, Inc (VSI) to Sell

Zacks Investment Research downgraded shares of Vitamin Shoppe, Inc (NYSE:VSI) from a hold rating to a sell rating in a report issued on Tuesday.

According to Zacks, “Vitamin Shoppe is a specialty retailer and direct marketer of nutritional products. It primarily sells vitamins, minerals, nutritional supplements, herbs, sports nutrition formulas, homeopathic remedies, green living products and health and beauty aids. Based in North Bergen, New Jersey, the company is recognized as an innovator in providing product information, associate training, and customer education. Information is available to consumers through unprecedented outlets including television, radio, friends, family, health practitioners, and the internet. It offers consumers the opportunity to take charge of their own health and wellness requirements, and supplement where necessary. At each store location, consumers can find a comprehensive Learning Center which offers free access to vital information about key health concerns and products. The Vitamin Shoppe is a strong supporter of health and wellness campaigns including Life Supplemented sponsored by the Council for Responsible Nutrition. “

Several other research firms have also commented on VSI. Morgan Stanley raised Vitamin Shoppe from an underweight rating to an equal weight rating and set a $14.00 price objective on the stock in a research report on Thursday, May 11th. Goldman Sachs Group, Inc. (The) reissued a sell rating and issued a $6.00 price objective (down from $13.00) on shares of Vitamin Shoppe in a research report on Thursday, August 10th. Gabelli lowered Vitamin Shoppe from a buy rating to a hold rating in a research report on Thursday, May 11th. BidaskClub lowered Vitamin Shoppe from a hold rating to a sell rating in a research report on Thursday, July 27th. Finally, ValuEngine lowered Vitamin Shoppe from a buy rating to a hold rating in a research report on Friday, June 2nd. Three analysts have rated the stock with a sell rating and seven have assigned a hold rating to the stock. The company presently has an average rating of Hold and a consensus price target of $15.71.

Shares of Vitamin Shoppe (NYSE VSI) opened at 5.90 on Tuesday. The stock’s market cap is $137.02 million. The firm’s 50-day moving average price is $9.75 and its 200 day moving average price is $15.37. Vitamin Shoppe has a one year low of $5.75 and a one year high of $28.41.

Vitamin Shoppe (NYSE:VSI) last issued its earnings results on Wednesday, August 9th. The specialty retailer reported $0.23 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.39 by $0.16. Vitamin Shoppe had a negative net margin of 11.98% and a positive return on equity of 8.33%. The firm had revenue of $304.84 million during the quarter, compared to analyst estimates of $314.74 million. During the same quarter in the previous year, the business posted $0.55 EPS. Vitamin Shoppe’s revenue was down 8.4% compared to the same quarter last year. Equities research analysts expect that Vitamin Shoppe will post $0.82 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This news story was originally reported by BNB Daily and is owned by of BNB Daily. If you are viewing this news story on another site, it was illegally copied and republished in violation of international trademark and copyright laws. The correct version of this news story can be read at https://www.baseball-news-blog.com/2017/08/19/zacks-investment-research-downgrades-vitamin-shoppe-inc-vsi-to-sell.html.

Several hedge funds have recently made changes to their positions in VSI. Norges Bank acquired a new stake in shares of Vitamin Shoppe during the fourth quarter worth about $6,444,000. Russell Investments Group Ltd. acquired a new stake in shares of Vitamin Shoppe during the first quarter worth about $462,000. Canada Pension Plan Investment Board raised its stake in shares of Vitamin Shoppe by 111.3% in the first quarter. Canada Pension Plan Investment Board now owns 131,200 shares of the specialty retailer’s stock worth $2,644,000 after buying an additional 69,100 shares during the last quarter. Great West Life Assurance Co. Can raised its stake in shares of Vitamin Shoppe by 7.7% in the first quarter. Great West Life Assurance Co. Can now owns 35,279 shares of the specialty retailer’s stock worth $707,000 after buying an additional 2,513 shares during the last quarter. Finally, LSV Asset Management raised its stake in shares of Vitamin Shoppe by 109.4% in the first quarter. LSV Asset Management now owns 76,648 shares of the specialty retailer’s stock worth $1,544,000 after buying an additional 40,048 shares during the last quarter.

About Vitamin Shoppe

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Get a free copy of the Zacks research report on Vitamin Shoppe (VSI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply